Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02433626
Title Study of COTI-2 as Monotherapy or Combination Therapy for the Treatment of Malignancies (COTI2-101)
Recruitment Unknown status
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Critical Outcome Technologies Inc.
Indications

head and neck squamous cell carcinoma

pancreatic cancer

lung cancer

fallopian tube cancer

peritoneum cancer

colorectal cancer

ovarian cancer

cervical cancer

Advanced Solid Tumor

endometrial cancer

Therapies

COTI-2

Cisplatin + COTI-2

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST